Sign in
Home
Media News
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
American Biotech News
Home
Media News
About Us
Contact Us
Home
Tags
Eli Lilly
Tag: Eli Lilly
Biotechnology
StockWatch: Illumina Stays Mum as Short Seller Targets Icahn
-
May 4, 2023
Biotechnology
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
-
November 17, 2022
Biotechnology
Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis
-
January 31, 2022
Biotechnology
EY Firepower Report: Biopharmas Choosing Collaborations over M&A
-
January 26, 2022
Biotechnology
U.S. OKs EUA for Genentech’s Actemra vs. COVID-19; Halts Distribution of...
-
June 28, 2021
Biotechnology
AbCellera, Lilly Advance Next-Generation Antibody vs. COVID-19
-
May 5, 2021
Biotechnology
U.S. Halts Distribution of Lilly’s Bamlanivimab Monotherapy, Citing SARS-CoV-2 Variant Resistance
-
March 25, 2021
Biotechnology
Eli Lilly, Regeneron Report Positive Phase III COVID-19 Antibody Results
-
January 27, 2021
Biotechnology
Adagio Aims to “Set the Bar Higher”
-
December 9, 2020
Biotechnology
Regeneron, Lilly Setbacks Raise Questions on the Effectiveness of Antibodies in...
-
November 2, 2020
1
2
Page 1 of 2
Edit with Live CSS